Novo Integrated Sciences Operating Income 2012-2024 | NVOS
Novo Integrated Sciences operating income from 2012 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
|
Novo Integrated Sciences Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $-10 |
| 2023 | $-9 |
| 2022 | $-25 |
| 2021 | $-4 |
| 2020 | $-4 |
| 2019 | $-1 |
| 2018 | $-2 |
| 2017 | $0 |
| 2016 | $0 |
| 2016 | $0 |
| 2015 | $0 |
| 2014 | $-1 |
| 2013 | $0 |
| 2012 | $-1 |
| 2012 | $-1 |
| 2011 | $-2 |
| 2011 | $-2 |
|
Novo Integrated Sciences Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2024-08-31 | $-3 |
| 2024-05-31 | $-3 |
| 2024-02-29 | $-2 |
| 2023-11-30 | $-3 |
| 2023-08-31 | $-3 |
| 2023-05-31 | $-1 |
| 2023-02-28 | $-2 |
| 2022-11-30 | $-2 |
| 2022-08-31 | $-20 |
| 2022-05-31 | $-1 |
| 2022-02-28 | $-2 |
| 2021-11-30 | $-1 |
| 2021-08-31 | $-2 |
| 2021-05-31 | $0 |
| 2021-02-28 | $-1 |
| 2020-11-30 | $-1 |
| 2020-08-31 | $-4 |
| 2020-05-31 | $0 |
| 2020-02-29 | $0 |
| 2019-11-30 | $0 |
| 2019-08-31 | $0 |
| 2019-05-31 | $0 |
| 2019-02-28 | $0 |
| 2018-11-30 | $0 |
| 2018-08-31 | $0 |
| 2018-05-31 | $0 |
| 2018-02-28 | $-1 |
| 2017-11-30 | $0 |
| 2017-08-31 | $-2 |
| 2017-05-31 | $0 |
| 2017-03-31 | $0 |
| 2017-02-28 | $0 |
| 2016-12-31 | |
| 2016-11-30 | $0 |
| 2016-09-30 | $0 |
| 2016-06-30 | $0 |
| 2016-05-31 | $0 |
| 2016-03-31 | $0 |
| 2015-12-31 | |
| 2015-09-30 | $0 |
| 2015-06-30 | $0 |
| 2015-03-31 | $0 |
| 2014-12-31 | |
| 2014-09-30 | $0 |
| 2014-06-30 | $0 |
| 2014-03-31 | $0 |
| 2013-12-31 | |
| 2013-09-30 | $0 |
| 2013-06-30 | $0 |
| 2013-03-31 | $0 |
| 2012-12-31 | $0 |
| 2012-09-30 | $0 |
| 2012-08-31 | |
| 2012-06-30 | $0 |
| 2012-03-31 | $0 |
| 2012-02-29 | $0 |
| 2011-12-31 | |
| 2011-11-30 | $-1 |
| 2011-09-30 | $-1 |
| 2011-08-31 | $0 |
| 2011-06-30 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.000B | $0.013B |
| Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |